3-Deazaadenosine, an S -adenosylhomocysteine hydrolase inhibitor, attenuates lipopolysaccharide-induced inflammatory responses via inhibition of AP-1 and NF-kappa B signaling
- Authors
- Yang, Woo Seok; Kim, Ji Hye; Jeong, Deok; Hong, Yo Han; Park, Sang Hee; Yang, Yoonyong; Jang, Young-Jin; Kim, Jong-Hoon; Cho, Jae Youl
- Issue Date
- Dec-2020
- Publisher
- PERGAMON-ELSEVIER SCIENCE LTD
- Keywords
- 3-Deazadenosine; S-adenosylhomocysteine hydrolase; Inflammation; MEK1/2; IKK alpha/beta
- Citation
- BIOCHEMICAL PHARMACOLOGY, v.182
- Indexed
- SCIE
SCOPUS
- Journal Title
- BIOCHEMICAL PHARMACOLOGY
- Volume
- 182
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/2454
- DOI
- 10.1016/j.bcp.2020.114264
- ISSN
- 0006-2952
1873-2968
- Abstract
- 3-Deazadenosine (3-DA) is a general methylation inhibitor that depletes S-adenosylmethionine, a methyl donor, by blocking S-adenosylhomocysteine hydrolase (SAHH). In this study, we investigated the inhibitory activity and molecular mechanisms of 3-DA in inflammatory responses. 3-DA suppressed the secretion of inflammatory mediators such as nitric oxide (NO) and prostaglandin E-2 (PGE(2)) in lipopolysaccharide-treated RAW264.7 cells and phorbol 12-myristate 13-acetate (PMA)-differentiated U937 cells. It also reduced mRNA expression of inducible nitric oxide synthase, cyclooxygenase-2, tumor necrosis factor-alpha, interleukin-1 beta (IL-1 beta), and IL-6, indicating that 3-DA has anti-inflammatory properties in murine and human macrophages. Moreover, 3-DA strongly blocked AP-1 and NF-kappa B luciferase activity under PMA-, MyD88-, and TRIF-stimulated conditions and decreased the translocation of c-Jun, c-Fos, p65, and p50 into the nucleus. In addition, the p-ERK level in AP-1 signaling and the p-I kappa B alpha level in NF-kB signaling were diminished by 3-DA treatment. Interestingly, 3-DA did not alter the phosphorylation of MEK1/2, an ERK modulator, or IKK alpha/beta, an I kappa B alpha regulator. Instead, 3-DA prevented MEK1/2 and IKK alpha/beta from combining with ERK and I kappa B alpha, respectively, and directly suppressed MEK1/2 and IKK alpha/beta kinase activity. These results indicate that MEK1/2 and IKK alpha/beta are direct targets of 3-DA. In addition, suppression of SAHH by siRNA or treatment with adenosine dialdehyde, another SAHH inhibitor, showed inhibitory patterns against p-ERK and I kappa B alpha similar to those of 3-DA. Taken together, this study demonstrates that 3-DA inhibits AP-1 and NF-kappa B signaling by directly blocking MEK1/2 and IKK alpha/beta or indirectly mediating SAHH, resulting in antiinflammatory activity.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Biotechnology and Bioengineering > Integrative Biotechnology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/2454)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.